|

Olverembatinib, APG-2575, Dexamethasone Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Institute of Hematology & Blood Diseases Hospital, China1

Indications

  • Leukemia, Lymphoblastic, Acute, Philadelphia-Positive1
  • Lymphoblastic Leukemia, Acute, Childhood1
  • Relapsed Leukemia1
  • Refractory Leukemia1
  • Cancer1

Other1 trial

Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.